NO832057L - Biostimulerende middel - Google Patents
Biostimulerende middelInfo
- Publication number
- NO832057L NO832057L NO832057A NO832057A NO832057L NO 832057 L NO832057 L NO 832057L NO 832057 A NO832057 A NO 832057A NO 832057 A NO832057 A NO 832057A NO 832057 L NO832057 L NO 832057L
- Authority
- NO
- Norway
- Prior art keywords
- hydrolyzate
- creatine
- biostimulant
- magnesium salt
- calcium
- Prior art date
Links
- 230000001764 biostimulatory effect Effects 0.000 title description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960003624 creatine Drugs 0.000 claims abstract description 10
- 239000006046 creatine Substances 0.000 claims abstract description 10
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940109850 royal jelly Drugs 0.000 claims abstract description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- QORVDGQLPPAFRS-XPSHAMGMSA-N galantamine hydrobromide Chemical compound Br.O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 QORVDGQLPPAFRS-XPSHAMGMSA-N 0.000 claims description 6
- 229960002024 galantamine hydrobromide Drugs 0.000 claims description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- 239000003531 protein hydrolysate Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 abstract description 3
- 229960003980 galantamine Drugs 0.000 abstract 2
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 16
- 239000000126 substance Substances 0.000 description 6
- 210000003169 central nervous system Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000001428 peripheral nervous system Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000003631 expected effect Effects 0.000 description 2
- 208000034657 Convalescence Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 244000058477 Sambucus melanocarpa Species 0.000 description 1
- 235000007052 Sambucus melanocarpa Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000011022 black elderberry Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 229940050411 fumarate Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 229960002901 sodium glycerophosphate Drugs 0.000 description 1
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Jellies, Jams, And Syrups (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823221827 DE3221827A1 (de) | 1982-06-09 | 1982-06-09 | Biostimulierendes mittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO832057L true NO832057L (no) | 1983-12-12 |
Family
ID=6165747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO832057A NO832057L (no) | 1982-06-09 | 1983-06-07 | Biostimulerende middel |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0098975B1 (cs) |
| JP (1) | JPS5962528A (cs) |
| AT (1) | ATE15604T1 (cs) |
| AU (1) | AU562517B2 (cs) |
| DE (1) | DE3221827A1 (cs) |
| GR (1) | GR77543B (cs) |
| NO (1) | NO832057L (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2134215T3 (es) * | 1991-05-14 | 1999-10-01 | Ernir Snorrason | Tratamiento de sindromes de fatiga con inhibidores de colinesterasa. |
| RU2124360C1 (ru) * | 1992-11-06 | 1999-01-10 | Борис Геннадиевич Хорхорин | Способ повышения иммунитета |
| CH688760A5 (de) * | 1995-04-28 | 1998-03-13 | Synergen Ag | Topisches Praeparat zur Foerderung des Muskelaufbaus. |
| DE19537494C2 (de) * | 1995-09-25 | 1997-10-02 | Desitin Arzneimittel Gmbh | Kreatin zum Schutz von neuralem Gewebe |
| AU3086897A (en) * | 1996-06-28 | 1998-01-21 | Ipr-Institute For Pharmaceutical Research Ag | Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc |
| ATE355066T1 (de) * | 1999-01-11 | 2006-03-15 | Atanas Russinov Djananov | Nahrungszusatz aus kräutern zur steigerung der muskulären kraft und ausdauer von athleten |
| US8603546B2 (en) | 1999-01-11 | 2013-12-10 | Herbaceuticals Inc. | Herbal supplement for increased muscle strength and endurance for athletes |
| AU5359801A (en) * | 2000-04-19 | 2001-11-07 | Humanetics Corp | A combination of pinitol and creatine to enhance uptake and retention of creatine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2254777A (en) * | 1936-08-26 | 1941-09-02 | Walther H Duisberg | Process of producing artificial staple fibers resembling wool |
| GB1012121A (en) * | 1961-03-13 | 1965-12-08 | Yamanouchi Pharma Co Ltd | A method of preparing a pharmacologically active protein material from royal bee jelly |
| FR1326611A (fr) * | 1962-04-05 | 1963-05-10 | Procédé d'activation de la gelée royale d'abeilles, produits pour la réalisationdu procédé et produits conformes à ceux obtenus par le présent procédé ou procédé similaire |
-
1982
- 1982-06-09 DE DE19823221827 patent/DE3221827A1/de not_active Withdrawn
-
1983
- 1983-06-07 AU AU15432/83A patent/AU562517B2/en not_active Ceased
- 1983-06-07 NO NO832057A patent/NO832057L/no unknown
- 1983-06-09 GR GR71611A patent/GR77543B/el unknown
- 1983-06-09 EP EP83105674A patent/EP0098975B1/de not_active Expired
- 1983-06-09 AT AT83105674T patent/ATE15604T1/de not_active IP Right Cessation
- 1983-06-09 JP JP58101859A patent/JPS5962528A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0098975B1 (de) | 1985-09-18 |
| AU1543283A (en) | 1983-12-15 |
| JPS5962528A (ja) | 1984-04-10 |
| ATE15604T1 (de) | 1985-10-15 |
| DE3221827A1 (de) | 1983-12-15 |
| AU562517B2 (en) | 1987-06-11 |
| GR77543B (cs) | 1984-09-24 |
| EP0098975A1 (de) | 1984-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7037522B2 (en) | Nocturnal muscle enhancing composition and method | |
| PT755633E (pt) | Preparacao bifasica | |
| CN104323283A (zh) | 含辅酶q10的营养组合物及其制备方法与应用 | |
| NO832057L (no) | Biostimulerende middel | |
| JP2001187736A (ja) | 滋養強壮剤及び滋養強壮飲食物 | |
| CN104474417A (zh) | 药食同源中药组合物及其用途、葡萄酒以及葡萄酒的制备方法 | |
| US20070280997A1 (en) | Composition for enhancing muscle recovery | |
| Hovhannisyan et al. | Efficacy of Adaptogenic Supplements on Adapting to Stress: A Randomized, Controlled Trial. J Athl Enhancement 4: 4 | |
| KR20010055274A (ko) | 항피로용 건강 보조식품 | |
| CN112618608A (zh) | 具有解酒功能的组合物及其制备方法和应用 | |
| CA1198058A (en) | Biostimulating agent | |
| CA2446254C (en) | New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits | |
| CN108355022A (zh) | 一种具有减肥解毒功效的中药保健制剂 | |
| Pahwa et al. | Pharmacokinetic comparison of Sinemet and Atamet (generic carbidopa/levodopa): a single‐dose study | |
| CN102579956A (zh) | 一种药物组合物及其应用 | |
| WO2012147051A2 (en) | Food, particularly a beverage for human consumption | |
| RU2152221C1 (ru) | Средство, обладающее гепатопротекторным, холестерино- и сахарорегулирующим действием | |
| Rawat et al. | Importance of Rasaushadhis in Ayurveda | |
| DE202015102038U1 (de) | Koffeinhaltige Zusammensetzung | |
| RU2809638C1 (ru) | Продукт специализированный с аргинином | |
| JP3060121U (ja) | ガラナとプロポリス入りソフトカプセル | |
| EP3707081B1 (en) | Device and method for the preparation and oral administration of a liquid composition | |
| RU2104012C1 (ru) | Фармацевтическая композиция на основе природного продукта, нормализующая обменные процессы в организме | |
| CN101524505A (zh) | 一种治疗腹泻的中药组合物 | |
| CN118680290A (zh) | 一种增强运动能力、缓解运动疲劳的组合物及其应用 |